Postischemic microvasculopathy and endothelial progenitor cell-based therapy in ischemic AKI: update and perspectives

被引:17
|
作者
Patschan, D. [1 ]
Kribben, A. [2 ]
Mueller, G. A. [1 ]
机构
[1] Univ Gottingen, Univ Hosp Gottingen, Clin Nephrol & Rheumatol, Gottingen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany
关键词
acute kidney injury; EPCs; microvasculopathy; ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; MESENCHYMAL STEM-CELLS; CISPLATIN-INDUCED NEPHROTOXICITY; REPERFUSION INJURY; MITOCHONDRIAL INJURY; BARRIER FUNCTION; PROXIMAL TUBULE; POTENTIAL ROLE; RAT MODEL;
D O I
10.1152/ajprenal.00232.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute kidney injury (AKI) dramatically increases mortality of hospitalized patients. Incidences have been increased in recent years. The most frequent cause is transient renal hypoperfusion or ischemia which induces significant tubular cell dysfunction/damage. In addition, two further events take place: interstitial inflammation and microvasculopathy (MV). The latter evolves within minutes to hours postischemia and may result in permanent deterioration of the peritubular capillary network, ultimately increasing the risk for chronic kidney disease (CKD) in the long term. In recent years, our understanding of the molecular/cellular processes responsible for acute and sustained microvasculopathy has increasingly been expanded. The methodical approaches for visualizing impaired peritubular blood flow and increased vascular permeability have been optimized, even allowing the depiction of tissue abnormalities in a three-dimensional manner. In addition, endothelial dysfunction, a hallmark of MV, has increasingly been recognized as an inductor of both vascular malfunction and interstitial inflammation. In this regard, so-called regulated necrosis of the endothelium could potentially play a role in postischemic inflammation. Endothelial progenitor cells (EPCs), represented by at least two major subpopulations, have been shown to promote vascular repair in experimental AKI, not only in the short but also in the long term. The discussion about the true biology of the cells continues. It has been proposed that early EPCs are most likely myelomonocytic in nature, and thus they may simply be termed proangiogenic cells (PACs). Nevertheless, they reliably protect certain types of tissues/organs from ischemia-induced damage, mostly by modulating the perivascular microenvironment in an indirect manner. The aim of the present review is to summarize the current knowledge on postischemic MV and EPC-mediated renal repair.
引用
收藏
页码:F382 / F394
页数:13
相关论文
共 50 条
  • [1] Endothelial progenitor cell-based therapy for hemophilia A
    Hideto Matsui
    International Journal of Hematology, 2012, 95 : 119 - 124
  • [2] Endothelial progenitor cell-based therapy for hemophilia A
    Matsui, Hideto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (02) : 119 - 124
  • [3] Endothelial progenitor cell-based neovascularization: implications for therapy
    Krenning, Guido
    van Luyn, Marja J. A.
    Harmsen, Martin C.
    TRENDS IN MOLECULAR MEDICINE, 2009, 15 (04) : 180 - 189
  • [4] Endothelial Progenitor Cell-Based Therapy for Pulmonary Arterial Hypertension
    Yang, Jin-Xiu
    Pan, Yan-Yun
    Zhao, You-Yang
    Wang, Xing-Xiang
    CELL TRANSPLANTATION, 2013, 22 (08) : 1325 - 1336
  • [5] ENDOTHELIAL PROGENITOR CELLS IN CELL-BASED THERAPY FOR CARDIOVASCULAR DISEASE
    Rodriguez-Losada, N.
    Garcia-Pinilla, J. M.
    Jimenez-Navarro, M. F.
    Gonzalez, F. J.
    CELLULAR AND MOLECULAR BIOLOGY, 2008, 54 (01) : 11 - 23
  • [6] Cell-Based Therapy for Ischemic Heart Disease: A Clinical Update
    Herrmann, Jeremy L.
    Abarbanell, Aaron M.
    Weil, Brent R.
    Wang, Yue
    Wang, Meijing
    Tan, Jiangning
    Meldrum, Daniel R.
    ANNALS OF THORACIC SURGERY, 2009, 88 (05): : 1714 - 1722
  • [7] Endothelial Progenitor Cells: A Novel Cell-based Therapy in Orthopaedic Surgery
    Atesok, Kivanc
    Li, Ru
    Schemitsch, Emil
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2012, 20 (10) : 672 - 674
  • [8] Endothelial progenitor cells in pulmonary hypertension - dawn of cell-based therapy?
    Toshner, M.
    Morrell, N. W.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 7 - 12
  • [9] Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke
    Kwak, Kyeong-Ah
    Kwon, Ho-Beom
    Lee, Joo Won
    Park, Young-Seok
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (28) : 3332 - 3340
  • [10] Cell-based therapy for ischemic stroke
    Zhang, Jing
    Chopp, Michael
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1229 - 1240